imlunestrant 200 MG [Inluriyo]

RxNorm concept 2725919, branded drug component (sbdc).

RxCUI: 2725919
Term type: Branded drug component (SBDC)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2725919 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

imlunestrant 2725912

Related concepts

imlunestrant 200 MG Oral Tablet [Inluriyo] (SBD, constitutes)
Inluriyo (BN, has ingredient)
imlunestrant 200 MG (SCDC, tradename of)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2725919 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2725919 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2725919. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.